Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
We have therefore identified that 1,25(OH)2D3 promotes α-1-antitrypsin synthesis by human CD4+ T cells: a novel cellular source of this protein.1,25(OH)2D3 drives α-1-antitrypsin expression by human peripheral CD4+ T cells, but not CD8+ T cells or monocytes.(a&b) CD4+ T cells, or (c) CD8+ T cells (1 × 106 in 1 ml), in RPMI 10%FCS, were stimulated with anti-CD3 (1 μg/ml) and IL-2 (50 u/ml) for two rounds of seven days, in presence of 1,25(OH)2D3 as indicated (a: n = 9, b: n = 4, c: n = 4). (d) Human purified peripheral CD14+ monocytes (1 × 106 in 1 ml), in RPMI 10%FCS, were stimulated with LPS (500 ng/ml) for 48 h in presence of 10−7 M 1,25(OH)2D3 as indicated (n = 4). α-1-Antitrypsin expression was assessed by (a) qPCR for SERPINA1 mRNA and (b: d) ELISA. mRNA quantification by qPCR was normalised to 18S transcription and is shown as a relative quantity (RQ) compared to expression under control conditions in vitro.
Source: 1,25(OH)2D3 induces α-1-antitrypsin expression by human CD4+ T cells. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D (1,25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1,25(OH)2D3-driven IL-10
Study design awaiting verification · The Journal of Steroid Biochemistry and Molecular Biology · 2019
Original publication title
Vitamin D (1,25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1,25(OH)2D3-driven IL-10
© 2019 The Authors
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Highlights
- •
Human CD4+ T cells exposed to 1,25(OH)2D3 secrete α-1-antitrypsin: representing a novel cellular source of this protein.
- •
α-1-Antitrypsin promotes IL-10 secretion by human CD4+ T cells, via direct interaction with complement C3a.
- •
1,25(OH)2D3 is unable to increase IL10 transcription in CD4+ T cells from α-1-antitrypsin-deficient individuals.
- •
Therefore, autocrine α-1-Antitrypsin is required for 1,25(OH)2D3-driven IL-10 expression.
Studies to identify novel immune-regulatory functions of active vitamin D (1,25(OH)2D3) in human CD4+ T cells revealed that 1,25(OH)2D3 potently induced expression of the gene SERPINA1, encoding the anti-protease α-1-antitrypsin. We confirmed α-1-antitrypsin protein expression by 1,25(OH)2D3-treated CD4+ T cells, but not in CD8+ T cells or monocytes. α-1-Antitrypsin promotes anti-inflammatory IL-10 synthesis in other immune cell populations. We therefore investigated its immune-regulatory effects in CD4+ T cells. Plasma-derived α-1-antitrypsin drove IL-10 synthesis by CD4+ T cells, which was not dependent on anti-protease activity, but appeared to require a serum-binding factor, since this could not be achieved with recombinant protein. α-1-Antitrypsin is reported to bind complement components, which regulate T cell function.
A role for this interaction was therefore probed. Plasma-derived, but not recombinant α-1-antitrypsin contained C3a. Surface Plasmon Resonance and Microscale Thermophoresis demonstrated α-1-antitrypsin binding to C3a. Addition of C3a to CD4+ T cells cultured with recombinant α-1-antitrypsin restored induction of IL-10, whereas neutralisation of C3a abrogated IL-10 induced by plasma-derived α-1-antitrypsin. To interrogate an endogenous role for the α-1-antitrypsin-C3a axis in 1,25(OH)2D3-driven CD4+ T cell IL-10 synthesis, we treated cells from healthy or α-1-antitrypsin-deficient individuals (which transcribe SERPINA1 but do not secrete protein) with 1,25(OH)2D3.
A significant correlation was identified between SERPINA1 and IL10 gene expression in healthy donor CD4+ T cells, which was absent in cells from α-1-antitrypsin-deficient individuals. Therefore, α-1-antitrypsin is required for 1,25(OH)2D3-induced IL-10 expression in CD4+ T cells, interacting with C3a to drive IL-10 expression.
Authors’ abstract
Highlights
- •
Human CD4+ T cells exposed to 1,25(OH)2D3 secrete α-1-antitrypsin: representing a novel cellular source of this protein.
- •
α-1-Antitrypsin promotes IL-10 secretion by human CD4+ T cells, via direct interaction with complement C3a.
- •
1,25(OH)2D3 is unable to increase IL10 transcription in CD4+ T cells from α-1-antitrypsin-deficient individuals.
- •
Therefore, autocrine α-1-Antitrypsin is required for 1,25(OH)2D3-driven IL-10 expression.
Studies to identify novel immune-regulatory functions of active vitamin D (1,25(OH)2D3) in human CD4+ T cells revealed that 1,25(OH)2D3 potently induced expression of the gene SERPINA1, encoding the anti-protease α-1-antitrypsin. We confirmed α-1-antitrypsin protein expression by 1,25(OH)2D3-treated CD4+ T cells, but not in CD8+ T cells or monocytes. α-1-Antitrypsin promotes anti-inflammatory IL-10 synthesis in other immune cell populations. We therefore investigated its immune-regulatory effects in CD4+ T cells. Plasma-derived α-1-antitrypsin drove IL-10 synthesis by CD4+ T cells, which was not dependent on anti-protease activity, but appeared to require a serum-binding factor, since this could not be achieved with recombinant protein. α-1-Antitrypsin is reported to bind complement components, which regulate T cell function.
A role for this interaction was therefore probed. Plasma-derived, but not recombinant α-1-antitrypsin contained C3a. Surface Plasmon Resonance and Microscale Thermophoresis demonstrated α-1-antitrypsin binding to C3a. Addition of C3a to CD4+ T cells cultured with recombinant α-1-antitrypsin restored induction of IL-10, whereas neutralisation of C3a abrogated IL-10 induced by plasma-derived α-1-antitrypsin. To interrogate an endogenous role for the α-1-antitrypsin-C3a axis in 1,25(OH)2D3-driven CD4+ T cell IL-10 synthesis, we treated cells from healthy or α-1-antitrypsin-deficient individuals (which transcribe SERPINA1 but do not secrete protein) with 1,25(OH)2D3.
A significant correlation was identified between SERPINA1 and IL10 gene expression in healthy donor CD4+ T cells, which was absent in cells from α-1-antitrypsin-deficient individuals. Therefore, α-1-antitrypsin is required for 1,25(OH)2D3-induced IL-10 expression in CD4+ T cells, interacting with C3a to drive IL-10 expression.
Publication and source details
Original title: Vitamin D (1,25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1,25(OH)2D3-driven IL-10
Sarah Dimeloe; Louise V. Rice; Hebe Chen; Charlotte Cheadle; John Raynes; Paul Pfeffer; Paul Lavender; David F. Richards; Mun Peak Nyon; James M. McDonnell; Claudia Kemper; Bibek Gooptu; Catherine M. Hawrylowicz
The Journal of Steroid Biochemistry and Molecular Biology · 2019
⁎ Corresponding author at: Asthma UK Centre for Allergic Mechanisms of Asthma, Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, 5th Floor Tower Wing, Guy’s Hospital, King’s College London, London, SE1 9RT, United Kingdom. catherine.hawrylowicz@kcl.ac.ukThese authors contributed equally to this work.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T20:03:31.005192+00:00
DOI: 10.1016/j.jsbmb.2019.01.014 · PMC6525112